Levels of SLC34A2 in “well-differentiated endometrioid” carcinomas are overexpressed [101], and patients with tumors of the brain, pancreas, and ovaries have reduced lifespans associated with SLC34A2 overexpression [102]. Here, SLC34A2 is linked to brain neoplasm.